GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (LTS:0NZY) » Definitions » Shares Outstanding (EOP)

Eckert & Ziegler SE (LTS:0NZY) Shares Outstanding (EOP) : 20.8 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Eckert & Ziegler SE Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Eckert & Ziegler SE's shares outstanding for the quarter that ended in Sep. 2024 was 20.8 Mil.

Eckert & Ziegler SE's quarterly shares outstanding stayed the same from Jun. 2024 (20.8 Mil) to Sep. 2024 (20.8 Mil).

Eckert & Ziegler SE's annual shares outstanding increased from Dec. 2022 (20.8 Mil) to Dec. 2023 (20.8 Mil). It means Eckert & Ziegler SE issued new shares from Dec. 2022 to Dec. 2023 .


Eckert & Ziegler SE Shares Outstanding (EOP) Historical Data

The historical data trend for Eckert & Ziegler SE's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Shares Outstanding (EOP) Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.59 20.59 20.76 20.80 20.83

Eckert & Ziegler SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.81 20.83 20.85 20.85 20.85

Competitive Comparison of Eckert & Ziegler SE's Shares Outstanding (EOP)

For the Medical Devices subindustry, Eckert & Ziegler SE's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's Shares Outstanding (EOP) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's Shares Outstanding (EOP) falls into.


;
;

Eckert & Ziegler SE Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Eckert & Ziegler SE  (LTS:0NZY) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Eckert & Ziegler SE Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Eckert & Ziegler SE Headlines

No Headlines